ABCA1: at the nexus of cholesterol, HDL and atherosclerosis

Trends in Biochemical Sciences

Volumn 32, Issue 4, 2007, Pages 172-179

  Attie, Alan D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ARTERY WALL; ATHEROSCLEROSIS; BLOOD FLOW; CELL MEMBRANE; CELL TRANSPORT; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; EPITHELIUM CELL; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; LIPOPROTEIN DEFICIENCY; LIPOPROTEIN SYNTHESIS; MACROPHAGE; NONHUMAN; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; REVIEW; TANGIER DISEASE;

ANIMALS; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; MODELS, BIOLOGICAL;

EUKARYOTA;

EID: 34247164170     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2007.02.001     Document Type: Review

References (81)

1. Lange Y. Disposition of intracellular cholesterol in human fibroblasts. J. Lipid Res. 32 (1991) 329-339
2. Simons K., and Ehehalt R. Cholesterol, lipid rafts, and disease. J. Clin. Invest. 110 (2002) 597-603
3. Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110 (2002) 905-911
4. Feng B., and Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J. Biol. Chem. 277 (2002) 43271-43280
5. Yao P.M., and Tabas I. Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J. Biol. Chem. 276 (2001) 42468-42476
6. Yao P.M., and Tabas I. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J. Biol. Chem. 275 (2000) 23807-23813
7. Feng B., et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell Biol. 5 (2003) 781-792
8. Schroder M., and Kaufman R.J. The mammalian unfolded protein response. Annu. Rev. Biochem. 74 (2005) 739-789
9. Blacklow S.C., and Kim P.S. Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor. Nat. Struct. Biol. 3 (1996) 758-762
10. Annilo T., et al. Evolution of the vertebrate ABC gene family: analysis of gene birth and death. Genomics 88 (2006) 1-11
11. Luciani M.F., et al. Cloning of two novel ABC transporters mapping on human chromosome 9. Genomics 21 (1994) 150-159
12. Luciani M.F., and Chimini G. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J. 15 (1996) 226-235
13. Hamon Y., et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat. Cell Biol. 2 (2000) 399-406
14. Rust S., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22 (1999) 352-355
15. Brooks-Wilson A., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 (1999) 336-345
16. Bodzioch M., et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22 (1999) 347-351
17. Lawn R.M., et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104 (1999) R25-R31
18. Ferrans V.J., and Fredrickson D.S. The pathology of Tangier disease. A light and electron microscopic study. Am. J. Pathol. 78 (1975) 101-158
19. Oram J.F., and Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37 (1996) 2473-2491
20. Francis G.A., et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Clin. Invest. 96 (1995) 78-87
21. Schreyer S.A., et al. Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens. Arterioscler. Thromb. 14 (1994) 2053-2059
22. Attie A.D., et al. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken. J. Lipid Res. 43 (2002) 1610-1617
23. Davis R.A. Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver. Biochim. Biophys. Acta 1440 (1999) 1-31
24. Bojanovski D., et al. In vivo metabolism of proapolipoprotein A-I in Tangier disease. J. Clin. Invest. 80 (1987) 1742-1747
25. Timmins J.M., et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115 (2005) 1333-1342
26. Mulligan J.D., et al. ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J. Biol. Chem. 278 (2003) 13356-13366
27. Brunham L.R., et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116 (2006) 1052-1062
28. Singaraja R.R., et al. Both hepatic and extrahepatic ABCA1 have discrete and essential functions in the maintenance of plasma high-density lipoprotein cholesterol levels In vivo. Circulation 114 (2006) 1301-1309
29. Repa J.J., et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
30. McNeish J., et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 4245-4250
31. Drobnik W., et al. ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism. Gastroenterology 120 (2001) 1203-1211
32. Neufeld E.B., et al. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem. Biophys. Res. Commun. 297 (2002) 974-979
33. Groen A.K., et al. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J. Clin. Invest. 108 (2001) 843-850
34. Graf G.A., et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J. Clin. Invest. 110 (2002) 659-669
35. Plosch T., et al. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1. J. Biol. Chem. 277 (2002) 33870-33877
36. Repa J.J., et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β. J. Biol. Chem. 277 (2002) 18793-18800
37. Berge K.E., et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290 (2000) 1771-1775
38. Lu K., et al. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am. J. Hum. Genet. 69 (2001) 278-290
39. Lee M.H., et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 27 (2001) 79-83
40. Yu L., et al. Selective sterol accumulation in ABCG5/ABCG8-deficient mice. J. Lipid Res. 45 (2004) 301-307
41. Plosch T., et al. Abcg5/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G414-G423
42. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
43. Greaves D.R., and Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J. Lipid Res. 46 (2005) 11-20
44. Moore K.J., and Freeman M.W. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 1702-1711
45. Haghpassand M., et al. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108 (2001) 1315-1320
46. van Eck M., et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 6298-6303
47. Van Eck M., et al. Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 929-934
48. Goldstein J.L., et al. Protein sensors for membrane sterols. Cell 124 (2006) 35-46
49. Kalaany N.Y., and Mangelsdorf D.J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68 (2006) 159-191
50. Janowski B.A., et al. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 266-271
51. Yang C., et al. Sterol intermediates from cholesterol biosynthetic pathway as LXR ligands. J. Biol. Chem. 281 (2006) 27816-27826
52. Wong J., et al. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1 by generating oxysterol ligands for LXR. Biochem. J. 400 (2006) 485-491
53. Joseph S.B., and Tontonoz P. LXRs: new therapeutic targets in atherosclerosis?. Curr. Opin. Pharmacol. 3 (2003) 192-197
54. Schultz J.R., et al. Role of LXRs in control of lipogenesis. Genes Dev. 14 (2000) 2831-2838
55. Burnham L.R., et al. Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levels. Circ. Res. 99 (2006) 672-674
56. Oram J.F., et al. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275 (2000) 34508-34511
57. Le Goff W., et al. Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 527-533
58. See R.H., et al. Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J. Biol. Chem. 277 (2002) 41835-41842
59. Wang N., et al. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275 (2000) 33053-33058
60. Wang N., et al. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111 (2003) 99-107
61. Newton R.S., and Krause B.R. HDL therapy for the acute treatment of atherosclerosis. Atheroscler. Suppl. 3 (2002) 31-38
62. Paszty C., et al. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94 (1994) 899-903
63. Plump A.S., et al. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9607-9611
64. Wang Y., and Oram J.F. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J. Biol. Chem. 277 (2002) 5692-5697
65. Brasaemle D.L., and Attie A.D. Rapid intracellular transport of LDL-derived cholesterol to the plasma membrane in cultured fibroblasts. J. Lipid Res. 31 (1990) 103-112
66. Baumann N.A., et al. Transport of newly synthesized sterol to the sterol-enriched plasma membrane occurs via nonvesicular equilibration. Biochemistry 44 (2005) 5816-5826
67. van Meer G., et al. ABC lipid transporters: extruders, flippases, or flopless activators?. FEBS Lett. 580 (2006) 1171-1177
68. Chroni A., et al. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43 (2004) 2126-2139
69. Wang N., et al. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276 (2001) 23742-23747
70. Rigot V., et al. Distinct sites on ABCA1 control distinct steps required for cellular release of phospholipids. J. Lipid Res. 43 (2002) 2077-2086
71. Fitzgerald M.L., et al. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J. Lipid Res. 45 (2004) 287-294
72. Dawson R.J.P., and Locher K.P. Structure of a bacterial multidrug ABC transporter. Nature 443 (2006) 180-185
73. Brunham L.R., et al. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu. Rev. Nutr. 26 (2006) 105-129
74. Trompier D., et al. Transition from dimers to higher oligomeric forms occurs during the ATPase cycle of the ABCA1 transporter. J. Biol. Chem. 281 (2006) 20283-20290
75. Denis M., et al. Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles. J. Biol. Chem. 279 (2004) 41529-41536
76. Kiss R.S., et al. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux. J. Lipid Res. 46 (2005) 1877-1887
77. Vaughan A.M., and Oram J.F. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J. Lipid Res. 44 (2003) 1373-1380
78. Cohen J.C., et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
79. Frikke-Schmidt R., et al. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J. Clin. Invest. 114 (2004) 1343-1353
80. Clee S.M., et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J. Clin. Invest. 106 (2000) 1263-1270
81. Singaraja R.R., et al. Specific mutations in ABCA1 have discrete effects on ABCA1 function and lipid phenotypes both in vivo and in vitro. Circ. Res. 99 (2006) 389-397